ORCID Profile
0000-0002-9166-1319
Current Organisation
Murdoch University
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: MDPI AG
Date: 19-03-2021
Abstract: (1) Background: Condomless anal sex and substance use are associated with STI risk among gay, bisexual, and other men who have sex with men (gbMSM). Our first study objective was to describe event-level sexual risk and substance use trends among gbMSM. Our second study objective was to describe substances associated with event-level sexual risk. (2) Methods: Data come from the Momentum Health Study in Vancouver, British Columbia and participants were recruited from 2012–2015, with follow-up until 2018. Stratified by self-reported HIV status, we used generalized estimating equations to assess trends of sexual event-level substance use and assessed interactions between substance use and time period on event-level higher risk sex defined as condomless anal sex with an HIV serodifferent or unknown status partner. (3) Results: Event-level higher risk anal sex increased across the study period among HIV-negative/unknown (baseline prevalence: 13% vs. study end prevalence: 29%) and HIV-positive gbMSM (baseline prevalence: 16% vs. study end prevalence: 38%). Among HIV-negative/unknown gbMSM, event-level erectile drug use increased, while alcohol use decreased over the study period. Overall, interactions between substance use and time on higher risk anal sex were not statistically significant, regardless of serostatus. However, we found a number of time-specific significant interactions for erectile drugs, poppers, Gamma-hydroxybutyrate (GHB), crystal meth hetamine and ecstasy/MDMA use among HIV-negative/unknown gbMSM. (4) Conclusion: Significant differences in substance use trends and associated risks exist and are varied among gbMSM by serostatus. These findings provide a more comprehensive understanding of the effects of event-level substance use on sexual risk through longitudinal follow-up of nearly six years.
Publisher: Informa UK Limited
Date: 14-05-2020
Publisher: Informa UK Limited
Date: 07-11-2022
DOI: 10.1080/09540121.2022.2142927
Abstract: HIV treatment interruptions are a
Publisher: Springer Science and Business Media LLC
Date: 03-05-2011
DOI: 10.1007/S12603-011-0065-X
Abstract: Alzheimer's Disease (AD) has been described as "one of the most disabling and burdensome health conditions worldwide" and is responsible for approximately 70% of dementia in the elderly. Based on the current prevalence of AD, an aging world population and the associated projected health care requirements, it is estimated that by 2050, the prevalence of AD will reach 104 million with around 43% requiring ongoing health care. If the onset of AD can be reduced by as little as one year, the prevalence could be reduced by 10%. There is substantial commonality in research findings to date around the positive influence of seafood consumption in reducing the risk of dementia and AD. Emerging concern about the sustainability of global fisheries supports the recommendation of selective consumption of sustainable wild caught and increased emphasis on production of farmed fish supplies to meet consumption needs.
Publisher: Wiley
Date: 14-01-2014
DOI: 10.1111/IJCS.12076
Publisher: Elsevier BV
Date: 08-2011
DOI: 10.1016/J.APPET.2011.03.015
Abstract: The general public is increasingly aware of the health benefits associated with consumption of omega-3 fatty acids. While evidence of health benefits continues to mount, the underlying science is complex. Omega-3 fatty acids vary in their physiological efficacy. Consumers are typically unaware of differences in the efficacy of different omega-3 fatty acids and this lack of knowledge can result in consumers being misled within the marketplace. There is a need for consumers to be educated about the distinctions between omega-3 fatty acids. In the interim consumers remain at risk of purchasing premium fortified products and supplements that will not correspond to their desired health outcomes. This paper summarises the current understanding of fatty acid physiological metabolism and interaction for the purpose of highlighting this complex and multifaceted concern.
Publisher: Wiley
Date: 15-08-2012
Publisher: Informa UK Limited
Date: 27-06-2022
DOI: 10.1080/00918369.2022.2089075
Abstract: Developmental and lifespan examinations of meth hetamine use among gay, bisexual, and other men who have sex with men (GBM) remain limited. We used a feminist trauma framework to examine potential links between childhood trauma, trauma-related stressors, and meth hetamine use among GBM. From June 2018 to October 2018, semi-structured interviews (
Publisher: OMICS Publishing Group
Date: 30-12-2010
DOI: 10.4066/AMJ.2010.442
Publisher: JMIR Publications Inc.
Date: 15-03-2016
DOI: 10.2196/JMIR.5258
Publisher: University of Toronto Press Inc. (UTPress)
Date: 04-2021
Abstract: Bear identity exists as an understudied subgroup among gay, bisexual and other men who have sex with men (gbMSM). Given associations between Body Mass Index (BMI) and Bear identity, we examined prevalence estimates and effect modification between Bear identity, BMI, and cardiovascular health. Data is from February 2012–February 2018 and comes from a longitudinal-cohort of gbMSM in Metro Vancouver, recruited using respondent-driven s ling (RDS). We conducted univariable and multivariable logistic regression using RDS weighting. A total of 161 (21.3%) gbMSM self-identified as a Bear/Cub/Otter (BCO) and 48 (7.2%) gbMSM who identified as a BCO had a measured BMI ≥ 30. Multivariable results found non-BCO identity and a BMI ≥ 30 (aOR = 11.27 95% CI = 2.88, 44.07) was associated with greater odds of history of cardiovascular health condition and/or associated risk factors compared to gbMSM who did not identify as a BCO and had a BMI 30. The majority of gbMSM with BMI ≥ 30 identified as a BCO. However, BCO identity was not the most significant effect modifier for BMI on a history of a cardiovascular health condition and/or associated risk factors. Interventions should target all gbMSM with increased risk for cardiovascular disease and clinicians should be mindful of culturally sensitive prevention and care for gbMSM who identify as a BCO.
Publisher: IMR Press
Date: 12-2011
Publisher: Springer Science and Business Media LLC
Date: 24-09-2021
Start Date: Start date not available
End Date: End date not available
Funder: Fisheries Research and Development Corporation
View Funded ActivityStart Date: 2011
End Date: 2012
Funder: Department of Agriculture, Fisheries and Forestry, Australian Government
View Funded Activity